Physicians' Academy for Cardiovascular Education

ESC Heart Failure 2018

PACE-CME.org was present at the ESC Heart Failure congress in Vienna, Austria (May 26-29). Find reporting material of presented trending heart failure news here.

HFpEF: from understanding the physiology to development of new treatments

10' education - May 27, 2018 - ESC Heart Failure 2018, Vienna - Carolyn Lam, MD - Singapore - Online CME
Prof. Carolyn Lam recognizes six mechanisms that play a role in the pathophysiology of HFpEF. She shares evidence why these mechanisms may be targeted for therapy.

Prof. Carolyn Lam recognizes six mechanisms that play a role in the pathophysiology of HFpEF. She shares evidence why these mechanisms may be targeted for therapy.

Diabetes & Obesity in HFpEF: New targets in heart failure management

10' education - May 27, 2018 - ESC Heart Failure 2018, Vienna - Prof. Rudolf de Boer - Groningen, The Netherlands - Online CME
Prof. De Boer summarises the interplay between obesity, diabetes and HFpEF, and how the first two conditions may be managed, to minimize their impact on the course of HFpEF.

Prof. De Boer summarises the interplay between obesity, diabetes and HFpEF, and how the first two conditions may be managed, to minimize their impact on the course of HFpEF.

GRAND DEBATE | Is catheter ablation superior to drugs in the treatment of patients with AF and HF?

ESC Heart Failure 2018, Vienna
ESC Heart Failure 2018, Vienna

ESC HF 2018 The second part of the Grand Debate on Drugs or interventions focused on the value of catheter ablation in comparison to drug for treatment of patients with both AF and HF.

GRAND DEBATE | HFmrEF is similar to HFrEF – or not?

ESC Heart Failure 2018, Vienna
ESC Heart Failure 2018, Vienna

ESC 2018 In this debate, it became clear that not all are convinced yet about the use of the new ejection fraction category HFmrEF that was introduced in the latest ESC HF Guidelines in 2016.

Much progress in HF therapy in past 3 decades, especially with combination therapy

News - May 28, 2018
A network meta-analysis showed that incremental use of disease-modifying therapies lowers hospitalizations and mortality, which supports guideline recommendations.

ESC HF 2018 A network meta-analysis showed that incremental use of disease-modifying therapies lowers hospitalizations and mortality, which supports guideline recommendations.

GRAND DEBATE I Drugs or interventions : Coronary revascularization in stable ischemic HF

ESC Heart Failure 2018 - Vienna
ESC Heart Failure 2018 - Vienna

ESC HF 2018 In this first debate, John Cleland and Eric Velazquez discussed whether coronary revascularization is superior to optimal medical therapy in stable HF patients.

Octogenarians with HFrEF also benefit from RAS inhibition

News - May 27, 2018
SwedeHF data show that RASi is associated with reduced morbidity and mortality in HF patients of 80 years and older. Absolute risk reduction is larger than in younger HF patients.

ESC HF 2018 SwedeHF data show that RASi is associated with reduced morbidity and mortality in HF patients of 80 years and older. Absolute risk reduction is larger than in younger HF patients.

Genotype-guided beta-blocker therapy to prevent atrial fibrillation in HF patients

News - May 27, 2018
Bucindolol specifically affects a certain polymorphism of the β-1 adrenergic receptor. Treatment of HF patients with this genotype did not prevent AF and AFl in HF patients.

ESC HF 2018 Bucindolol specifically affects a certain polymorphism of the β-1 adrenergic receptor. Treatment of HF patients with this genotype did not prevent AF and AFl in HF patients.

‘Exergaming’ can help some HF patients to become more active and feel better

News - May 27, 2018
Playing of video games that require rigorous physical exercise yielded significant effects on exercise capacity and well-being in some HF patients.

ESC HF 2018 Playing of video games that require rigorous physical exercise yielded significant effects on exercise capacity and well-being in some HF patients.

Beta-blockers reduce all-cause and CV mortality in non-diabetic and diabetic HF patients

News - May 27, 2018
A large study on individual patient data shows that diabetic HF patients who are not obese have the highest mortality. Obesity attenuates the prognostic impact of beta-blockers.

ESC HF 2018 A large study on individual patient data shows that diabetic HF patients who are not obese have the highest mortality. Obesity attenuates the prognostic impact of beta-blockers.

Temporary hemodynamic improvement after splanchnic nerve block

News - May 26, 2018
In a small, first-in-man, proof-of-concept study, bilateral splanchnic nerve block improved hemodynamics, patient symptoms and physiological markers, for up to 90 minutes

ESC HF 2018 In a small, first-in-man, proof-of-concept study, bilateral splanchnic nerve block improved hemodynamics, patient symptoms and physiological markers, for up to 90 minutes

First truly world-wide AHF registry reveals differences across the globe

News - May 26, 2018
The REPORT-HF registry allows prospective and longitudinal analyses across seven regions in the world. Patients with acute heart failure are not the same everywhere, which affects therapy.

ESC HF 2018 The REPORT-HF registry allows prospective and longitudinal analyses across seven regions in the world. Patients with acute heart failure are not the same everywhere, which affects therapy.